CYTOCARE 502

Product Description

CYTOCARE 502 is an advanced rejuvenating complex specifically designed for early intervention in younger patients to enhance skin hydration and proactively prevent fine lines and wrinkles. Developed by Laboratoire Revitacare, this product features a unique combination of low-concentration hyaluronic acid and a revitalizing vitamin complex. Ideal for superficial dermis injections, CYTOCARE 502 supports professionals in delivering superior skin quality improvements through effective mesotherapy treatments.

CYTOCARE 502 Dosage and Administration

CYTOCARE 502 10x5ml is provided as follows:

• Each package contains 10 sterile vials, each with 5ml of injectable solution. 

Recommended administration guidelines:

• Inject into the superficial dermis using mesotherapy techniques. 
• Typical protocols involve one treatment session every 2 to 3 weeks over an initial cycle of 4–6 treatments. 
• Follow-up treatments for maintenance every 2–3 months, depending on individual patient needs. 
• Administration must be carried out by trained healthcare professionals experienced in injectable aesthetic treatments. 

Ingredient Information

CYTOCARE 502 combines carefully selected active ingredients:

• Non-cross-linked hyaluronic acid (2mg/ml) for optimal hydration and subtle volumization. 
• Vitamins and minerals enhancing cellular activity, antioxidant protection, and revitalization. 
• Amino acids and essential nutrients that stimulate skin regeneration and improve dermal elasticity. 

This revitalizing complex ensures targeted rejuvenation effects and superior skin quality improvements.

Storage Instructions

• Store CYTOCARE 502 between 2°C and 25°C (36°F to 77°F). 
• Protect from direct sunlight, moisture, and freezing. 
• Maintain product integrity in original, sealed packaging until use. 
• Do not use after expiration date or if packaging is compromised. 

Proper storage guarantees efficacy, safety, and consistency of treatment outcomes.

CYTOCARE 502 Contraindications

Avoid the use of CYTOCARE 502 in patients who:

• Are pregnant or breastfeeding. 
• Have allergies or hypersensitivity to hyaluronic acid or other ingredients. 
• Present active skin infections, inflammatory conditions, or open wounds at intended treatment sites. 
• Have autoimmune or immunocompromised conditions without prior medical evaluation. 

CYTOCARE 502 Precautions and Warnings

• Administer only by licensed and trained medical professionals in sterile clinical environments. 
• Conduct thorough patient assessments including medical history, allergies, and current medication. 
• Clearly instruct patients about post-treatment care to enhance results and reduce risks. 
• Closely observe patients immediately after treatment for prompt management of any adverse reactions. 

CYTOCARE 502 Manufacturer and Regulatory Information

CYTOCARE 502 is produced by Laboratoire Revitacare, a respected French pharmaceutical company known for innovative and scientifically supported mesotherapy solutions.

• Fully compliant with European CE standards and international regulatory requirements. 
• Manufactured under rigorous quality assurance processes. 
• Trusted internationally by healthcare providers for clinical effectiveness and patient safety. 

Clinicians who choose to order CYTOCARE 502 from Kinami Health benefit from guaranteed authenticity, consistent clinical performance, and comprehensive support for achieving optimal patient outcomes.